BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Epperly R, Gottschalk S, Velasquez MP. Harnessing T Cells to Target Pediatric Acute Myeloid Leukemia: CARs, BiTEs, and Beyond. Children (Basel) 2020;7:E14. [PMID: 32079207 DOI: 10.3390/children7020014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Gauthier L, Virone-Oddos A, Beninga J, Rossi B, Nicolazzi C, Amara C, Blanchard-Alvarez A, Gourdin N, Courta J, Basset A, Agnel M, Guillot F, Grondin G, Bonnevaux H, Bauchet AL, Morel A, Morel Y, Chiron M, Vivier E. Control of acute myeloid leukemia by a trifunctional NKp46-CD16a-NK cell engager targeting CD123. Nat Biotechnol 2023. [PMID: 36635380 DOI: 10.1038/s41587-022-01626-2] [Reference Citation Analysis]
2 Obszański P, Kozłowska A, Wańcowiat J, Twardowska J, Lejman M, Zawitkowska J. Molecular-Targeted Therapy of Pediatric Acute Myeloid Leukemia. Molecules 2022;27:3911. [PMID: 35745032 DOI: 10.3390/molecules27123911] [Reference Citation Analysis]
3 Hebbar N, Epperly R, Vaidya A, Thanekar U, Moore SE, Umeda M, Ma J, Patil SL, Langfitt D, Huang S, Cheng C, Klco JM, Gottschalk S, Velasquez MP. CAR T cells redirected to cell surface GRP78 display robust anti-acute myeloid leukemia activity and do not target hematopoietic progenitor cells. Nat Commun 2022;13. [DOI: 10.1038/s41467-022-28243-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
4 Reinhardt D, Antoniou E, Waack K. Pediatric Acute Myeloid Leukemia—Past, Present, and Future. JCM 2022;11:504. [DOI: 10.3390/jcm11030504] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
5 Epperly R, Gottschalk S, Velasquez MP. Biology and Clinical Evaluation of T/NK Cell Engagers. Cancer Drug Discovery and Development 2022. [DOI: 10.1007/978-3-030-87849-8_17] [Reference Citation Analysis]
6 Richards RM, Zhao F, Freitas KA, Parker KR, Xu P, Fan A, Sotillo E, Daugaard M, Oo HZ, Liu J, Hong WJ, Sorensen PH, Chang HY, Satpathy AT, Majzner RG, Majeti R, Mackall CL. NOT-Gated CD93 CAR T Cells Effectively Target AML with Minimized Endothelial Cross-Reactivity. Blood Cancer Discov 2021;2:648-65. [PMID: 34778803 DOI: 10.1158/2643-3230.BCD-20-0208] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
7 Lim J, Sari-Ak D, Bagga T. Siglecs as Therapeutic Targets in Cancer. Biology (Basel) 2021;10:1178. [PMID: 34827170 DOI: 10.3390/biology10111178] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
8 Stevens AM, Redell MS. Introduction to the Special Issue on Pediatric Acute Myeloid Leukemia: Current Management and Future Directions. Children (Basel) 2021;8:698. [PMID: 34438589 DOI: 10.3390/children8080698] [Reference Citation Analysis]